Collectively, the small-molecular agonist JAC4 of the JWA gene inhibited EGFR-driven lung-cancer growth and metastasis via the AMPK-NEDD4L-EGFR axis (Figure 9). This evidence concerns the gene EGFR and lung carcinoma.